MAPT and prion disease: We also observed an increased upregulation of Serpina3n protein, a serine protease inhibitor previously identified in human amyloid deposits [60] and dysregulated in prion diseases [61], which might indicate a role for Tau aggregates in the metabolism of these diseases.